Page 27 - 《中国药房》2022年12期
P. 27
with thrombolysis in intracerebral haemorrhage evacuation lncRNA structures and interactions by sequencing-based
(MISTIE Ⅲ):a randomised,controlled,open-label,blin- approaches[J]. Trends Biochem Sci,2019,44(1):33-52.
ded endpoint phase 3 trial[J]. Lancet,2019,393(10175): [27] GAO S,CHENG Q C,HU Y G,et al. LncRNA AK148321
1021-1032. alleviates neuroinflammation in LPS-stimulated BV2
[22] 路文杰,王泽颖,肖萌,等.祛风痰法干预进展性脑卒中的 microglial cell through regulating microRNA-1199-5p/
临床观察[J].中西医结合心脑血管病杂志,2015,13(7): HSPA5 axis[J]. Life Sci,2021,266:118863.
952-953. [28] CUEVAS-DIAZ DURAN R,WEI H,KIM D H,et al.
[23] 刘颖,张楠,艾民.活血化瘀法治疗高血压性脑出血的临 Invited review:long non-coding RNAs:important regula-
床疗效[J].中国老年学杂志,2019,39(11):2605-2607. tors in the development,function and disorders of the cen-
[24] LIANG P,MAO L S,MA Y,et al. A systematic review on tral nervous system[J]. Neuropathol Appl Neurobiol,
Zhilong Huoxue Tongyu capsule in treating cardiovascu- 2019,45(6):538-556.
lar and cerebrovascular diseases:pharmacological actions, [29] GIL N,ULITSKY I. Regulation of gene expression by
molecular mechanisms and clinical outcomes[J]. J Ethno- cis-acting long non-coding RNAs[J]. Nat Rev Genet,
pharmacol,2021,277:114234. 2020,21(2):102-117.
[25] BRAGA E A,FRIDMAN M V,MOSCOVTSEV A A, [30] MANNING G,WHYTE D B,MARTINEZ R,et al. The
et al. LncRNAs in ovarian cancer progression,metastasis, protein kinase complement of the human genome[J].
and main pathways:CeRNA and alternative mecha- Science,2002,298(5600):1912-1934.
nisms[J]. Int J Mol Sci,2020,21(22):E8855. (收稿日期:2022-01-05 修回日期:2022-05-05)
[26] QIAN X Y,ZHAO J Y,YEUNG P Y,et al. Revealing (编辑:邹丽娟)
(上接第1414页)
[ 5 ] WU M M. Research on quality improvement of undergra- org.uk/process/pmg19/chapter/acknowledgements.
duate thesis based on TQM concept[EB/OL].[2022-01-11]. [13] NICE. Guide to the methods of technology appraisal 2013
https://www.atlantis-press.com/proceedings/ichssr-19/125- [EB/OL].(2013-04-04)[2022-03-31]. https://www.nice.org.
909152. uk/process/pmg9/chapter/foreword.
[ 6 ] STABILE M E. An examination of the total quality ma- [14] IQWiG. Quality assurance of IQWiG assessment[EB/OL].
nagement(TQM)concept given current Federal/DoD com- [2022-04-01]. https://www.who.int/medical_devices/asse-
petition initiatives[EB/OL].[2022-01-11]. https://ui.adsabs. ssment/en/.https://htai.org/about-htai/.
harvard.edu/abs/1992MsT.........18S/abstract. [15] IQWiG. General methods:version,6:IQWiG[EB/OL].
[ 7 ] 郑锴,杨美娟,郝峰.全面质量管理在综合医院住院诊疗 (2020-11-05)[2022-04-01]. https://www.iqwig.de/me-
管理中的运用探讨[J].中国医院管理,2015,35(11):41- thoden/general-methods_version-6-0.pdf.
42. [16] 谢金平,邵蓉.英国NICE药品卫生技术评估和决策框架
[ 8 ] 李娟,张杨,杜杏利,等.基于全面质量管理的临床药学服 体系研究及启示[J].中国卫生经济,2020,39(12):114-
务体系[J].中国医院,2016,20(2):43-44. 119.
[ 9 ] 崔芳芳,孙东旭,曹明波,等.基于TQM的O2O医药电商 [17] BELETSI A,KOUTRAFOURI V,KARAMPLI E,et al.
服务质量控制体系研究[J].中国卫生事业管理,2021,38 Comparing use of health technology assessment in phar-
(4):244-247. maceutical policy among earlier and more recent adopters
[10] NICE. Who we are?[EB/OL].[2022-4-29]. https://www. in the European Union[J]. Value Health Reg Issues,2018,
nice.org.uk/about/who-we-are. 16:81-91.
[11] IQWiG. Social code book:book Ⅴ :statutory health in- [18] 霍玉雯,任平,田雪晴,等.药品临床综合评价基础信息平
surance[EB/OL].(1988-12-20). [2022-04-24]. https://www. 台建设构想[EB/OL].[2022-04-01]. http://biomedrxiv.org.
gesetze-im-internet.de/sgb_5/index.html. cn/article/pdf/display/bmr.202110.000006.
[12] NICE. Guide to the process of technology appraisal 2014 (收稿日期:2022-04-14 修回日期:2022-05-19)
[EB/OL].(2014-09-02)[2022-03-31]. https://www.nice. (编辑:孙 冰)
中国药房 2022年第33卷第12期 China Pharmacy 2022 Vol. 33 No. 12 ·1429 ·